This report analyzes the worldwide markets for Antibiotics in US$ Million by the following product segments: Penicillin, Cephalosporins, Macrolides, Quinolones, Carbapenems, and Other Antibiotics (Aminoglycosides, Tetracyclines, Sulfonamides, Mupirocin, Glycopeptides, Synercid, and Oxazolidinones).

Antibiotics – An IntroductionAntibiotic Resistanceb–LactamsClassification of AntibioticsKey Milestones in Antibiotic DevelopmentAntibiotic TypesPenicillinHistoryAbout the DrugCephalosporinsTreatmentEffects of the DrugMacrolidesTreatmentQuinolones

CarbapenemsOther AntibioticsAminoglycosidesTreatmentEffects of the DrugTetracyclinesTreatmentEffects of the DrugSulfonamidesTreatmentEffects of the DrugMupirocinGlycopeptidesSynercidOxazolidinonesLinezolid

6.RESEARCH FINDINGS

New Design for Monitoring Toxin Delivery Activity of Pathogenic BacteriaCephalosporins Effective when Compared to PenicillinFDA Bans Baytril Antibiotic for ChickensErythromycin Along with Some Specific Drugs Increase Risk of Sudden DeathRise in Usage of Quinolones for Urinary Tract Infections Leads to Drug ResistancePolyphor Discovers POL7080 - New Antibiotic Against Gram-Negative Bacteria

Toyama Launches New Garenoxacin Quinolone AntibioticWockhardt to Introduce Cefprozil in the USMSD India Launches Invanza in IndiaOrchid Chemicals to Introduce Three New Drugs in the USDUSA Pharmaceuticals Releases ClindaReach™Mylan Releases Cipro’s Generic VersionMacrolide Antibiotic Developed In the USUniversity of Michigan Devises NMR Spectroscopy For AntibioticsGlycopeptide-Cephalosporin Antibiotics Developed In The USNeosil Tests NEO 101 AntibioticNew Antibiotic Developed By Canadian InventorsAbbott Canada Releases FACTIVE® Antibiotic Tablets In CanadaPenicillin Binding Protein Found In JapanVenus Remedies Releases Mucomelt-Forte

Table 31. US Recent Past, Current & Future Analysis for Antibiotics by Product Segment – Penicillin, Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 32. US Historic Review for Antibiotics by Product Segment – Penicillin, Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics MarketsIndependently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)

Table 34. Canadian Recent Past, Current & Future Analysis for Antibiotics by Product Segment – Penicillin, Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 35. Canadian Historic Review for Antibiotics by Product Segment – Penicillin,Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)

Table 68. Rest of World Recent Past, Current & Future Analysis for Antibiotics by Product Segment – Penicillin, Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics Markets Independently Analyzed with Annual Sales in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)

Table 69. Rest of World Historic Review for Antibiotics by Product Segment – Penicillin, Cephalosporin, Macrolides,Quinolones, Carbapenems and Other Antibiotics Markets Independently Analyzed with Annual Sales in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart)